News & Events
Stay up-to-date with our news and our latest developments
New: NGSgo-AmpX v3 Whole Gene for HLA-DRB1, DQB1, and DPB1
We are excited to announce the expansion of our NGSgo-AmpX v3 product line with the introduction of three new products: […]
Single Locus HLA typing to maximize flexibility on ONT
We are very excited to share with you the launch of NGSgo-ProntoFLX, a powerful singleplex and duplex HLA gene amplification […]
The role of HLA in immunotherapy development
Human Leukocyte Antigen (HLA) proteins have long been central in the transplantation field, because of their critical role on transplant […]
Meet GenDx at EFI 2026
We are happy to announce that GenDx will be present at EFI 2026 in Edinburgh with a platinum sponsorship! The […]
GenDx and Treos Bio Announce Partnership to develop HLA-based Companion Diagnostic for PolyPEPI1018 Cancer Immunotherapy
PRESS RELEASE Utrecht and London, 17 March 2026 GenDx, a Eurobio Scientific Company, based in the Netherlands, specialized in molecular […]
Navigating Grey Zones & Growing Pains: Developments in the Regulatory CDx Space
๐ฅ๐ฒ๐ด๐ถ๐๐๐ฒ๐ฟ ๐ณ๐ผ๐ฟ ๐ผ๐๐ฟ ๐ป๐ฒ๐ ๐๐ฒ๐ฏ๐ถ๐ป๐ฎ๐ฟ! During this webinar,ย Kirsten van Garsse (QbD Group)ย andย Jules Petitย will discuss key elements of our joint panel […]
